Results 91 to 100 of about 4,886,491 (254)

What Do We Mean When We Talk About Transparency? Toward Meaningful Transparency in Commercial Content Moderation

International Journal of Communication, 2019
This article seeks to provide greater specificity to demands for transparency in the commercial content moderation practices of digital platforms. We identify gaps in knowledge through a thematic analysis of 380 survey responses from individuals who ...
Nicolas P. Suzor, Sarah Myers West, Andrew Quodling, Jillian York   +3 more
doaj  

TRES APUNTES SOBRE EL RECURSO DE NULIDAD Y EL ENJUICIAMIENTO FÁCTICO A PROPÓSITO DE TRES FALLOS DE LA ILUSTRÍSIMA CORTE DE APELACIONES DE LA SERENA

Revista de Derecho (Coquimbo)
La regulación del sistema de recursos tiene diversas deficiencias más o menos acusadas, que a nuestro juicio están relacionadas con dos cuestiones fundamentales.
Carlos del Río Ferretti
doaj   +1 more source

Can the Right To Be Heard Be Respected without Access to Information about the Proceedings? Deficiencies of National Competition Procedure [PDF]

Yearbook of Antitrust and Regulatory Studies, 2012
This article analyses Polish competition procedure from the perspective of a) the right to be heard, and b) the right to receive information about the proceedings.
Maciej Bernatt
doaj  

Nephrogenic Rests/Nephroblastomatosis in Patients With Unilateral Wilms Tumor Are Not Associated With an Increased Risk of Relapse: An Analysis of Patients Treated on the SIOP‐WT‐2001 Protocol in the SIOP‐UK‐CCLG and SIOP‐GPOH Studies (2001–2022)

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Nephrogenic rests (NRs) and nephroblastomatosis (NBM) are precursor lesions for development of Wilms tumor (WT). Their association with the risk of relapse has not been properly assessed, partly due to misunderstanding of their diagnostic criteria and terminology.
Gordan M. Vujanić, Rhoikos Furtwängler, Tanzina Chowdhury, Christian Vokuhl, Jenny Wegert, Norbert Graf   +5 more
wiley   +1 more source

Administering Blinatumomab via Continuous Intravenous Infusion in Pediatric Patients—A Single‐Institution Retrospective Review

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Blinatumomab, a CD19xCD3 bispecific T‐cell engager, has become standard therapy for children with de novo B‐cell acute lymphoblastic leukemia (B‐ALL). This retrospective review describes the experience of blinatumomab administration in pediatric patients.
Julia M. Hurley, Ryleigh Krueger, Kellie Joyce, James Stanley, Mary Waskerwitz‐Freyer, Marielle Klunder, David J. Hoogstra   +6 more
wiley   +1 more source

Occurrence of Extramedullary Relapses in Pediatric Acute Lymphoblastic Leukemia After Treatment With Blinatumomab

Pediatric Blood &Cancer, EarlyView.
ABSTRACT We report a retrospective single‐center analysis of pediatric patients with relapsed or refractory B‐cell precursor acute lymphoblastic leukemia focusing on relapses outside of the typical locations, bone marrow, central nervous system, or testes.
Johanna Kunz, Martin Ebinger, Michaela Döring, Markus Mezger, Ursula Holzer, Rupert Handgretinger, Peter Lang, Manon Queudeville   +7 more
wiley   +1 more source

Evaluating the Readability of Patient‐Facing Online Educational Materials for Pediatric Leukemia and Lymphoma

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Together, leukemia and lymphoma account for 38.7% of newly diagnosed pediatric cancer cases in the United States each year. Many caregivers utilize online resources to inform medical health decisions. Understanding the readability of these materials is critical to ensuring comprehensible patient education.
Chloe Strege, Simone Intriago Tito, Courtney Popp, William C. Miller, Cindy Eide, Christen Ebens, Jakub Tolar   +6 more
wiley   +1 more source

Due Process in Medical Education: Legal Considerations. [PDF]

Acad Pathol, 2018
Conran RM, Elzie CA, Knollmann-Ritschel BE, Domen RE, Powell SZ.   +4 more
europepmc   +1 more source

Time to Diagnosis Among Children and Adolescents With Cancer in Québec, Canada: A Population‐Based Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Timely cancer diagnosis in children and adolescents is important to improving outcomes. We aimed to quantify time to diagnosis and assess variations by patient, demographic and system‐level factors. Procedure We conducted a population‐based study of individuals aged 0–19 years diagnosed with one of 12 cancers from 2010 to 2022 in ...
Callum Mullen, Ronald D. Barr, Erin Strumpf, Mariam El‐Zein, Eduardo L. Franco, Talía Malagón   +5 more
wiley   +1 more source

Licensing and due process in the turnover of bacterial RNA. [PDF]

RNA Biol, 2013
Bandyra KJ, Luisi BF.
europepmc   +1 more source